Hans Olof Sjögren (Former)
1 – 10 of 28
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2013
-
Mark
Zebularine induces long-term survival of pancreatic islet allotransplants in streptozotocin treated diabetic rats.
(
- Contribution to journal › Article
- 2012
-
Mark
An epigenetic mechanism for high, synergistic expression of indoleamine 2,3-dioxygenase 1 (IDO1) by combined treatment with zebularine and IFN-γ: Potential therapeutic use in autoimmune diseases.
(
- Contribution to journal › Article
- 2011
-
Mark
Different toxicity profiles for drug-versus radionuclide-conjugated BR96 monoclonal antibodies in a syngeneic rat colon carcinoma model
(
- Contribution to journal › Article
- 2010
-
Mark
High-Dose Radioimmunotherapy Combined With Extracorporeal Depletion in a Syngeneic Rat Tumor Model
(
- Contribution to journal › Article
- 2007
-
Mark
Improved tumor targeting and decreased normal tissue accumulation through extracorporeal affinity adsorption in a two-step pretargeting strategy
(
- Contribution to journal › Article
-
Mark
Low dose Zebularine treatment enhances immunogenicity of tumor cells
(
- Contribution to journal › Article
- 2002
-
Mark
Interstitial laser thermotherapy of a rat liver adenocarcinoma
(
- Contribution to journal › Article
- 1999
-
Mark
Regression of intracerebral rat glioma isografts by therapeutic subcutaneous immunization with interferon-gamma, interleukin-7, or B7-1-transfected tumor cells
(
- Contribution to journal › Article
- 1996
-
Mark
Cure of established, intracerebral rat gliomas induced by therapeutic immunizations with tumor cells and purified APC or adjuvant IFN-gamma treatment
(
- Contribution to journal › Article
- 1995
-
Mark
Increased proportion of CD8+ tumor responsive T cells after immunization with tum- versus tum+ rat glioma
(
- Contribution to journal › Article